Algorae Pharmaceuticals Limited
LVCLF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $13,203 | $16,710 | $18,597 | $8,989 |
| - Cash | $469 | $3,108 | $4,111 | $4,239 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $12,733 | $13,601 | $14,486 | $4,750 |
| Revenue | $0 | $125 | $42 | $3 |
| % Growth | -100% | 198% | 1,134% | – |
| Gross Profit | $0 | $125 | $41 | $3 |
| % Margin | – | 100% | 98.7% | 78.2% |
| EBITDA | $0 | -$1,579 | -$1,521 | -$1,459 |
| % Margin | – | -1,261.3% | -3,619.7% | -42,848.3% |
| Net Income | -$803 | -$2,096 | -$2,108 | -$1,957 |
| % Margin | – | -1,673.8% | -5,016.3% | -57,483.1% |
| EPS Diluted | -0.001 | -0.001 | -0.002 | -0.002 |
| % Growth | 61.5% | 18.8% | 27.3% | – |
| Operating Cash Flow | -$1 | -$1,523 | -$1,986 | -$2,042 |
| Capital Expenditures | $0 | $0 | $0 | -$4 |
| Free Cash Flow | -$1 | -$1,523 | -$1,986 | -$2,046 |